Flow Traders U.S.’s BIO-key International BKYI Stock Holding History

Flow Traders U.S.’s Portfolio BKYI Stock Details BKYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,127	Closed	-$6K	–	1016
2025 Q4	$6K	Buy	+1,127	New	+$8.61K	﹤0.01%	863

Other funds holding BKYI

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Flow Traders U.S.'s BKYI Position: Q1 2026 in Review

Flow Traders U.S. sold out of BIO-key International (BKYI) in Q1 2026, closing a stake of 1,127 shares — an estimated $6K sold.

Flow Traders U.S. first reported a position in BKYI in Q4 2025 and held it in 1 quarter. The position peaked at $6K in Q4 2025. 10 funds tracked by Wall St. Rank hold BKYI as of Q1 2026.

Flow Traders U.S. reported no remaining BIO-key International position as of Q1 2026 after selling out during the quarter.
Flow Traders U.S. sold 1,127 BIO-key International shares in Q1 2026, an estimated $6K.
Flow Traders U.S. first reported a position in BIO-key International in Q4 2025 and held it in 1 quarter.
Flow Traders U.S.'s BIO-key International position peaked at $6K in Q4 2025.
10 funds tracked by Wall St. Rank held BIO-key International as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.